Market Cap 547.51B
Revenue (ttm) 94.19B
Net Income (ttm) 26.80B
EPS (ttm) N/A
PE Ratio 21.05
Forward PE 19.70
Profit Margin 28.46%
Debt to Equity Ratio 0.50
Volume 9,346,600
Avg Vol 8,930,486
Day's Range N/A - N/A
Shares Out 2.41B
Stochastic %K 88%
Beta 0.34
Analysts Strong Sell
Price Target $231.44

Company Profile

Johnson & Johnson, together with its subsidiaries, engages in the research and development, manufacture, and sale of various products in the healthcare field worldwide. It operates in two segments, Innovative Medicine and MedTech. The Innovative Medicine segment offers products for various therapeutic areas, such as immunology, including rheumatoid arthritis, psoriatic arthritis, inflammatory bowel disease, and psoriasis; infectious diseases comprising HIV/AIDS; neuroscience, consisting of mood...

Industry: Drug Manufacturers - General
Sector: Healthcare
Phone: 732 524 0400
Website: www.jnj.com
Address:
One Johnson & Johnson Plaza, New Brunswick, United States
Suite510
Suite510 Feb. 4 at 3:32 AM
$JNJ $KVUE How much will this cost JNJ, they are running out of time. The figure might be in the 7 Figures per plaintiff per Seeking Alpha Article 1/30. In a recent 658-page ruling, Judge Wolfson cleared plaintiffs’ experts to testify that J&J’s talc products are linked to ovarian cancer.
0 · Reply
Suite510
Suite510 Feb. 4 at 1:25 AM
$JNJ $KVUE $UBER Johnson & Johnson has lost multiple, high-profile lawsuits, including a $1.5 billion verdict in Jan 2026 and a $40 million verdict in Dec
1 · Reply
Suite510
Suite510 Feb. 4 at 1:23 AM
$UBER $JNJ $KVUE Two large companies with HUGE LEGAL Liabilities in 2026 This time Junk n Junk will file a real bankruptcy not a fake bankruptcy 😂⛷️👋🦃 there goes the cash 💵 Jury Deliberations Begin, With Plaintiffs Seeking $144M in Uber Sex Assault Trial
1 · Reply
Jack90
Jack90 Feb. 3 at 11:47 PM
$MRK $PFE $JNJ adding some here
0 · Reply
DoubleDownDave
DoubleDownDave Feb. 3 at 8:13 PM
$JNJ https://www.bitchute.com/video/Z7e1WLoOctZ2/
1 · Reply
topstockalerts
topstockalerts Feb. 3 at 7:17 PM
$JNJ Is it going higher?? Comment below
0 · Reply
erevnon
erevnon Feb. 3 at 7:10 PM
RBC Capital maintains Johnson & Johnson $JNJ at Outperform and raises the price target from $240 to https://marketsblock.com/stock-upgrades-and-downgrades/
0 · Reply
T_rizzz
T_rizzz Feb. 3 at 5:23 PM
$JNJ this won’t stay up here long
0 · Reply
Trader_Ty
Trader_Ty Feb. 3 at 4:53 PM
$JNJ One I watched and just didn't pull the trigger. Beauty 9 ride
0 · Reply
Sunny3999
Sunny3999 Feb. 3 at 4:38 PM
$PMN MCAP of $35 Million for an Alzheimer solution with Fast Track designation and DSMB approval without ARIA! This is a 1 billion MCAP in the making easily a 10 bagger. News with $175 Million financing last week! $JNJ $LLY $PFE $PMN $REGN
0 · Reply
Latest News on JNJ
What's Behind The 50% Surge In JNJ Stock?

Feb 3, 2026, 8:47 AM EST - 15 hours ago

What's Behind The 50% Surge In JNJ Stock?


Ariel Focus Fund Q4 2025 Portfolio Review

Feb 1, 2026, 10:35 AM EST - 2 days ago

Ariel Focus Fund Q4 2025 Portfolio Review

ADT AMG B FISV MOS ORCL


This Winning Fund Pro Likes J&J, Lowe's, and Utility Stocks

Jan 29, 2026, 12:42 PM EST - 5 days ago

This Winning Fund Pro Likes J&J, Lowe's, and Utility Stocks

LOW


Johnson & Johnson: Strong Momentum Heading Into 2026

Jan 28, 2026, 9:38 AM EST - 6 days ago

Johnson & Johnson: Strong Momentum Heading Into 2026


Best Dividend Kings: January 2026

Jan 25, 2026, 10:11 PM EST - 9 days ago

Best Dividend Kings: January 2026

ABBV ABM ABT ADM ADP AWR BDX


Johnson & Johnson is doing 'great things for patients,' CFO says

Jan 22, 2026, 12:15 AM EST - 12 days ago

Johnson & Johnson is doing 'great things for patients,' CFO says


Johnson & Johnson (JNJ) Q4 2025 Earnings Call Transcript

Jan 21, 2026, 1:56 PM EST - 13 days ago

Johnson & Johnson (JNJ) Q4 2025 Earnings Call Transcript


Nasdaq Edges Lower; Johnson & Johnson Earnings Top Estimates

Jan 21, 2026, 12:15 PM EST - 13 days ago

Nasdaq Edges Lower; Johnson & Johnson Earnings Top Estimates


Johnson & Johnson reports Q4 and Full-Year 2025 results

Jan 21, 2026, 6:20 AM EST - 13 days ago

Johnson & Johnson reports Q4 and Full-Year 2025 results


Is Johnson & Johnson A Dividend Stock, Or Something Else?

Jan 19, 2026, 8:00 AM EST - 15 days ago

Is Johnson & Johnson A Dividend Stock, Or Something Else?


The 2026 Dogs Of The Dow: 10 High-Yield Blue Chips

Jan 11, 2026, 7:40 AM EST - 23 days ago

The 2026 Dogs Of The Dow: 10 High-Yield Blue Chips

AMGN CVX HD KO MRK NKE PG


Cramer's Mad Dash: Johnson & Johnson

Jan 9, 2026, 9:59 AM EST - 25 days ago

Cramer's Mad Dash: Johnson & Johnson


Best Dividend Aristocrats For January 2026

Dec 31, 2025, 8:47 AM EST - 4 weeks ago

Best Dividend Aristocrats For January 2026

ABBV ABT ADM ADP AFL ALB AMCR


The Big 3: JNJ, SNDK, TWLO

Dec 30, 2025, 1:31 PM EST - 5 weeks ago

The Big 3: JNJ, SNDK, TWLO

TWLO SNDK


More Upside For JNJ Stock In 2026?

Dec 30, 2025, 5:05 AM EST - 5 weeks ago

More Upside For JNJ Stock In 2026?


Dogs of the Dow Had a Strong Year as Dividends Paid Off

Dec 29, 2025, 1:56 PM EST - 5 weeks ago

Dogs of the Dow Had a Strong Year as Dividends Paid Off

HD IBM NKE UNH


Suite510
Suite510 Feb. 4 at 3:32 AM
$JNJ $KVUE How much will this cost JNJ, they are running out of time. The figure might be in the 7 Figures per plaintiff per Seeking Alpha Article 1/30. In a recent 658-page ruling, Judge Wolfson cleared plaintiffs’ experts to testify that J&J’s talc products are linked to ovarian cancer.
0 · Reply
Suite510
Suite510 Feb. 4 at 1:25 AM
$JNJ $KVUE $UBER Johnson & Johnson has lost multiple, high-profile lawsuits, including a $1.5 billion verdict in Jan 2026 and a $40 million verdict in Dec
1 · Reply
Suite510
Suite510 Feb. 4 at 1:23 AM
$UBER $JNJ $KVUE Two large companies with HUGE LEGAL Liabilities in 2026 This time Junk n Junk will file a real bankruptcy not a fake bankruptcy 😂⛷️👋🦃 there goes the cash 💵 Jury Deliberations Begin, With Plaintiffs Seeking $144M in Uber Sex Assault Trial
1 · Reply
Jack90
Jack90 Feb. 3 at 11:47 PM
$MRK $PFE $JNJ adding some here
0 · Reply
DoubleDownDave
DoubleDownDave Feb. 3 at 8:13 PM
$JNJ https://www.bitchute.com/video/Z7e1WLoOctZ2/
1 · Reply
topstockalerts
topstockalerts Feb. 3 at 7:17 PM
$JNJ Is it going higher?? Comment below
0 · Reply
erevnon
erevnon Feb. 3 at 7:10 PM
RBC Capital maintains Johnson & Johnson $JNJ at Outperform and raises the price target from $240 to https://marketsblock.com/stock-upgrades-and-downgrades/
0 · Reply
T_rizzz
T_rizzz Feb. 3 at 5:23 PM
$JNJ this won’t stay up here long
0 · Reply
Trader_Ty
Trader_Ty Feb. 3 at 4:53 PM
$JNJ One I watched and just didn't pull the trigger. Beauty 9 ride
0 · Reply
Sunny3999
Sunny3999 Feb. 3 at 4:38 PM
$PMN MCAP of $35 Million for an Alzheimer solution with Fast Track designation and DSMB approval without ARIA! This is a 1 billion MCAP in the making easily a 10 bagger. News with $175 Million financing last week! $JNJ $LLY $PFE $PMN $REGN
0 · Reply
Tigerpicko
Tigerpicko Feb. 3 at 4:24 PM
$LEGN $JNJ $STOCKTWITS always going to $16 territory from all the troubles they have currently, will not gain track until earnings out and l don’t mean March l mean in May from Q1 2026, my lowest was predicted at $13 it’s in the $16 range today so enoughs enough - Company does not help the situation and been very poor communication, they knew this was coming (Jessie) if not they would have addressed this within the last 6 months, but they haven’t because they know more than they are communicating, and hello it’s here to $16 from $40 plus range, I’m not confident anymore, I used to get communication responses from them but not in last 3 months, giving me no confidence in the board turning it around anytime soon and the lack of addressing the current stock value, so I’ve sold out poured all into my other stocks, disappointed its come to this but out of 15 stocks in my portfolio this is the worst performer by 60% in 6 months rest haven been green every month so it’s time to move on.
0 · Reply
Sunny3999
Sunny3999 Feb. 3 at 4:14 PM
$PMN MCAP of $35 Million for an Alzheimer solution with Fast Track designation and DSMB approval without ARIA! This is a 1 billion MCAP in the making easily a 10 bagger $ABBV $CELG $JNJ $PFE
0 · Reply
DerpyTrades
DerpyTrades Feb. 3 at 3:07 PM
$JNJ $XLP Maybe I'm just Derpy, but I thought that Consumer Staples and companies like JNJ hitting ATHs and breaking multi-month Res lines was a risk-off sign. Granted, JNJ hasn't confirmed above that line yet and it has had a few false breaks in the past, but still.
0 · Reply
peloswing
peloswing Feb. 3 at 2:21 PM
$BMY broke out on the weekly chart. Reporting earnings Thursday morning, with an implied move of +/-4.62% ↕️ - Bristol Myers Squibb just launched a campaign with Johnson & Johnson $JNJ
0 · Reply
RonaldMeadows1095
RonaldMeadows1095 Feb. 3 at 5:13 AM
$JNJ $MA Consistent compounders
0 · Reply
Suite510
Suite510 Feb. 3 at 3:30 AM
$JNJ $KVUE $LLY I am Sticking around for the real talc bankruptcy or offering, i said that months ago lol 😂🤓, this dude just got it together on 1/30. lol 😂 Clearly, it is practically impossible for JNJ to pay out 7 figure sums to every claimant - the company would have to declare itself bankrupt in such a scenario, let alone its spun-out companies. Equally clearly, the market is not factoring in the risk of JNJ paying out tens of billions of dollars to claimants in 2026, or even, perhaps, this decade, although JNJ is certainly a cash rich company.
1 · Reply
RunnerSignals
RunnerSignals Feb. 2 at 9:38 PM
Stock Upgrades Today $META $TME $HOOD $UBER $JNJ wrapping up the list https://stocksrunner.com/news/2026-02-02-stock-upgrades-today
0 · Reply
CoolE
CoolE Feb. 2 at 9:15 PM
$JNJ 😍
0 · Reply
MadMaverick
MadMaverick Feb. 2 at 5:34 PM
🚨 $MTVA: The Next Frontier in the Obesity & GLP-1 Market 🔹 High-Growth Play: Direct exposure to the multi-billion dollar obesity and metabolic health sector. 🔹 Clinical Catalyst: Advancing DA-1726, a dual-agonist drug with best-in-class potential for weight loss. 🔹 Fully Funded: Recently secured $9.3M in capital to drive upcoming clinical milestones. 🔹 Pure Proxy: A high-upside public-market vehicle for the next wave of biotech breakthroughs. Why $MTVA stands out: 🔸 Targets both Obesity and MASH—two of the largest unmet needs in modern medicine. 🔸 Strong Phase 1b data showing significant weight loss results and a clean safety profile. 🔸 Positioned for momentum as the global demand for GLP-1 treatments skyrockets. MTVA looks rough so far in 2026 with price and sentiment tanking. However, despite the sell-off, volume is starting to surge, showing some life under the surface. Communicated Disclaimer - https://chartingdaily.com/metabolic-health $NVO $LLY $BMY $JNJ
1 · Reply
ripster47
ripster47 Feb. 2 at 6:22 AM
Day 2 + Psych Level Repeatable Setup $JNJ Example Watch the video to learn how to trade this repeatable pattern🎯 https://x.com/i/status/2018127351658459280
0 · Reply
Watson42
Watson42 Feb. 2 at 5:04 AM
$JNJ $GLAXO.NSE $MRK $SPY Operation Warp Speed addressed the Covid crisis. Notably, the Fed had already expanded before the pandemic began, suggesting its error wasn’t tardiness but premature action. (Image: Watson42/Gimp)
0 · Reply
Mandisng223
Mandisng223 Feb. 1 at 8:34 PM
0 · Reply